Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Depression and Anxiety|July 22, 2021
Moral distress in frontline healthcare workers in the initial epicenter of the COVID-19 pandemic in the United States: Relationship to PTSD symptoms, burnout, and psychosocial functioningSonya B Norman, Jordyn H Feingold, Halley Kaye-Kauderer, et al.Chronic Stress (Thousand Oaks, Calif.)|February 18, 2021
Psychological Impact of the COVID-19 Pandemic on Frontline Health Care Workers During the Pandemic Surge in New York CityJordyn H Feingold, Lauren Peccoralo, Chi C Chan, et al.Elife|November 5, 2025
Sox9 prevents retinal degeneration and is required for limbal stem cell differentiation in the adult mouse eyeAlicia Hurtado, Victor López-Soriano, Miguel Lao, et al.Gynecologic Oncology|October 25, 2024
Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016-01)Jesus García-Donas, Andres Redondo, Ana Santaballa, et al.Biorxiv : the Preprint Server for Biology|June 5, 2026
Supporting-like cells constitute an alternative steroidogenic lineage conserved in amniotesIván Barberá-Aura, Wai-Yee Chung, Emilie Dujardin, et al.Nature Structural & Molecular Biology|February 24, 2026
Chromatin spatial analysis by METALoci unveils sex-determining 3D regulatory hubsIrene Mota-Gómez, Juan Antonio Rodríguez, Shannon Dupont, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 31, 2024
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01)Jesus Garcia-Donas, Laia Garrigos, Nuria Lainez, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 28, 2023
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03Jesus Garcia-Donas, Alicia Hurtado, Laia Garrigos, et al.Journal of Geriatric Oncology|December 16, 2017
Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysisLaura Visa, Paula Jiménez-Fonseca, Elena Asensio Martínez, et al.Science (New York, N.Y.)|October 9, 2020
The mole genome reveals regulatory rearrangements associated with adaptive intersexualityFrancisca M Real, Stefan A Haas, Paolo Franchini, et al.Pageof 6